sphingosylphosphorylcholine

sphingosylphosphorylcholine is a lipid of Sphingolipids (SP) class. Sphingosylphosphorylcholine is associated with abnormalities such as Cerebral Vasospasm, Subarachnoid Hemorrhage, Atherosclerosis, Hypertensive disease and Niemann-Pick Diseases. The involved functions are known as MAP kinase kinase activity, JUN kinase activity, Phosphorylation, biphenyl synthase activity and Cell Death. Sphingosylphosphorylcholine often locates in Adipose tissue, Protoplasm, Body tissue, Membrane and Extracellular. The associated genes with sphingosylphosphorylcholine are UCN3 gene, MAPK9 gene, JUN gene, NAA50 gene and P4HTM gene. The related lipids are Lysophospholipids, lysophosphatidic acid, Lysophosphatidylcholines, Sphingolipids and Saponin. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of sphingosylphosphorylcholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with sphingosylphosphorylcholine?

sphingosylphosphorylcholine is suspected in Atherosclerosis, Niemann-Pick Diseases, Hypercholesterolemia, Dermatitis, Atopic, Chronic eczema, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with sphingosylphosphorylcholine

MeSH term MeSH ID Detail
Lupus Erythematosus, Systemic D008180 43 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Seizures D012640 87 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Endotoxemia D019446 27 associated lipids
Niemann-Pick Disease, Type A D052536 1 associated lipids
Niemann-Pick Disease, Type B D052537 1 associated lipids
Total 8

PubChem Associated disorders and diseases

What pathways are associated with sphingosylphosphorylcholine

Lipid pathways are not clear in current pathway databases. We organized associated pathways with sphingosylphosphorylcholine through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with sphingosylphosphorylcholine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with sphingosylphosphorylcholine?

Mouse Model

Mouse Model are used in the study 'Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes.' (Sekiguchi K et al., 1999).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with sphingosylphosphorylcholine

Download all related citations
Per page 10 20 50 100 | Total 248
Authors Title Published Journal PubMed Link
Yoneda H et al. A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study. 2014 World Neurosurg pmid:23032083
Carson MJ and Lo D Immunology. The push-me pull-you of T cell activation. 2001 Science pmid:11474091
Kabarowski JH et al. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. 2001 Science pmid:11474113
Ghosh TK et al. Intracellular calcium release mediated by sphingosine derivatives generated in cells. 1990 Science pmid:2163543
Aksu F et al. Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats. 2016 Ren Fail pmid:27309733
Baek S et al. DJ-1 Regulates Differentiation of Human Mesenchymal Stem Cells into Smooth Muscle-like Cells in Response to Sphingosylphosphorylcholine. 2017 Proteomics pmid:28949093
Han M et al. Effect of direct albumin binding to sphingosylphosphorylcholine in Jurkat T cells. 2007 Prostaglandins Other Lipid Mediat. pmid:17991619
Lynch KR and Macdonald TL Structure activity relationships of lysophospholipid mediators. 2001 Prostaglandins Other Lipid Mediat. pmid:11324706
Wang XQ et al. Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway. 2014 Prostaglandins Other Lipid Mediat. pmid:24614064
Hodgson DM et al. Lysosphingomyelin prevents behavioral aberrations and hippocampal neuron loss induced by the metabotropic glutamate receptor agonist quisqualate. 1999 Prog. Neuropsychopharmacol. Biol. Psychiatry pmid:10509381
Nixon GF et al. The multi-functional role of sphingosylphosphorylcholine. 2008 Prog. Lipid Res. pmid:18042469
Berger A et al. Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7597047
Tobo A et al. Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses. 2015 PLoS ONE pmid:26070068
Yang CR et al. The G protein coupled receptor 3 is involved in cAMP and cGMP signaling and maintenance of meiotic arrest in porcine oocytes. 2012 PLoS ONE pmid:22685609
El-Najjar N et al. Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients. 2015 PLoS ONE pmid:26466367
Welford RW et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. 2014 PLoS ONE pmid:25479233
Fox LM et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. 2009 PLoS Biol. pmid:19859526
Higuchi K et al. Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes. 2003 Pigment Cell Res. pmid:14629725
Kim DS et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. 2006 Pigment Cell Res. pmid:16524430
Sundh M et al. Influence of phase separating lipids on supported lipid bilayer formation at SiO2 surfaces. 2010 Phys Chem Chem Phys pmid:20023823
Huwiler A and Pfeilschifter J Lipids as targets for novel anti-inflammatory therapies. 2009 Pharmacol. Ther. pmid:19576246
Davenport AP et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. 2013 Pharmacol. Rev. pmid:23686350
Yasukochi M et al. Ca2+ and voltage dependence of cardiac ryanodine receptor channel block by sphingosylphosphorylcholine. 2003 Pflugers Arch. pmid:12632186
Yagmurlu A et al. A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling. 2004 Pediatr. Surg. Int. pmid:15185106
Brandts B et al. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes. 2000 Pacing Clin Electrophysiol pmid:11139931
Kim HJ et al. Novel involvement of RhebL1 in sphingosylphosphorylcholine-induced keratin phosphorylation and reorganization: Binding to and activation of AKT1. 2017 Oncotarget pmid:28209923
Kishi H et al. [Involvement of Fyn tyrosine kinase and membrane rafts in the signal transduction in Ca2+-sensitization of vascular smooth muscle contraction]. 2007 Nippon Yakurigaku Zasshi pmid:17435334
Ohno K [Niemann-Pick disease types A and B]. 1995 Nippon Rinsho pmid:8577051
Kudo R and Hatake K [Effect of ethanol on sphingosylphosphorylcholine (SPC)-induced vasoconstriction in rat artery]. 2010 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:20681251
Calcerrada MC et al. Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei. 1999 Neurosci. Res. pmid:10211767
Hashiba Y et al. Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries. 2007 Neurol. Res. pmid:17806208
Rodriguez-Lafrasse C and Vanier MT Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. 1999 Neurochem. Res. pmid:9972865
Yi H et al. Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells. 2011 Neurochem. Res. pmid:21674237
Czyborra C et al. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16521006
Ryu SK et al. Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16521007
Hemmings DG Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16570136
Beil M et al. Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. 2003 Nat. Cell Biol. pmid:12942086
Xu Y et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. 2000 Nat. Cell Biol. pmid:10806476
Retraction. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. 2006 Nat. Cell Biol. pmid:16508674
Horii K et al. Development of a sphingosylphosphorylcholine detection system using RNA aptamers. 2010 Molecules pmid:20729797
Himmel HM et al. Guanine nucleotide-sensitive inhibition of L-type Ca2+ current by lysosphingolipids in RINm5F insulinoma cells. 1998 Mol. Pharmacol. pmid:9584212
Van Koppen CJ et al. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. 1996 Mol. Pharmacol. pmid:8649355
Berger A et al. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity. 1996 Mol. Pharmacol. pmid:8794881
Brailoiu E and Dun NJ Extra- and intracellular sphingosylphosphorylcholine promote spontaneous transmitter release from frog motor nerve endings. 2003 Mol. Pharmacol. pmid:12761354
Chuang WL et al. Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients. 2014 Mol. Genet. Metab. pmid:24418695
Vanier MT et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review. 2016 Mol. Genet. Metab. pmid:27339554
Afrasiabi E et al. Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase. 2007 Mol. Cell. Endocrinol. pmid:17606321
Yang LV et al. Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor. 2007 Mol. Cell. Biol. pmid:17145776
Jeong HS et al. PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation. 2012 Mol. Cell. Biochem. pmid:22544520
Neri LM et al. Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 2002 Mol. Biol. Cell pmid:11907274
Bae YC et al. Effects of sphingosylphosphorylcholine on cryopreserved fat tissue graft survival. 2016 Mol Med Rep pmid:27572900
Herzog C et al. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. 2010 Mediators Inflamm. pmid:21274265
Chen PF et al. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells. 1998 Kidney Int. pmid:9844123
Harris LJ et al. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. 2011 J. Surg. Res. pmid:19959190
Seuwen K et al. Receptors for protons or lipid messengers or both? 2006 J. Recept. Signal Transduct. Res. pmid:17118800
Mogi C et al. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. 2005 J. Pharmacol. Sci. pmid:16210776
Katayama T et al. Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells. 2006 J. Pharmacol. Sci. pmid:17072099
Kim DS et al. Sphingosylphosphorylcholine inhibits melanin synthesis via pertussis toxin-sensitive MITF degradation. 2010 J. Pharm. Pharmacol. pmid:20487197
Aksu B et al. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. 2009 J. Pediatr. Surg. pmid:19361629
Aksu B et al. Effects of sphingosylphosphorylcholine against oxidative stress and acute lung ınjury ınduced by pulmonary contusion in rats. 2015 J. Pediatr. Surg. pmid:25840069
Lu X and Bittman R Synthesis of a photoactivatable (2S,3R)-sphingosylphosphorylcholine analogue. 2005 J. Org. Chem. pmid:15932314
Ignatov A et al. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. 2003 J. Neurosci. pmid:12574419
Higuchi K et al. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. 2001 J. Lipid Res. pmid:11590211
Okamoto R et al. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. 2003 J. Lipid Res. pmid:12518027
Bittman R and Verbicky CA Methanolysis of sphingomyelin. Toward an epimerization-free methodology for the preparation of D-erythro-sphingosylphosphocholine. 2000 J. Lipid Res. pmid:11108743
Xin C et al. Sphingosylphosphorylcholine acts in an anti-inflammatory manner in renal mesangial cells by reducing interleukin-1beta-induced prostaglandin E2 formation. 2007 J. Lipid Res. pmid:17592175
Jeon ES et al. Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. 2006 J. Lipid Res. pmid:16339111
Sripada PK et al. Partial synthesis and properties of a series of N-acyl sphingomyelins. 1987 J. Lipid Res. pmid:3611973
Sueyoshi N et al. Preparation of a naturally occurring D-erythro-(2S, 3R)-sphingosylphosphocholine using Shewanella alga NS-589. 1997 J. Lipid Res. pmid:9323602
Tokura Y et al. Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine. 1999 J. Investig. Dermatol. Symp. Proc. pmid:10536997
Imokawa G et al. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. 1999 J. Invest. Dermatol. pmid:9886270
Kye KC et al. Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. 2004 J. Invest. Dermatol. pmid:15175025
Andoh T et al. Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. 2009 J. Invest. Dermatol. pmid:19657356
Sun L et al. A new wound healing agent--sphingosylphosphorylcholine. 1996 J. Invest. Dermatol. pmid:8601721
Murata Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? 1996 J. Invest. Dermatol. pmid:8752664
Wakita H et al. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9506444
van Diggelen OP et al. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. 2005 J. Inherit. Metab. Dis. pmid:16151905
Lee HY et al. Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells. 2011 J. Immunol. pmid:21368227
Takenouchi T et al. Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway. 2008 J. Immunol. pmid:18523246
Imokawa G A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. 2009 J. Dermatol. Sci. pmid:19443184
Kim HJ et al. Sphingosylphosphorylcholine induces degranulation of mast cells in the skin and plasma exudation in the ears of mice. 2010 J. Dermatol. Sci. pmid:19889516
Kwon YB et al. Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts. 2007 J. Dermatol. Sci. pmid:17321112
Fujiwaki T et al. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16431168
Fujiwaki T et al. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease. 2008 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:18502707
Wirrig C et al. Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. 2011 J. Cereb. Blood Flow Metab. pmid:20551970
Shirao S et al. A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts. 2015 J. Cereb. Blood Flow Metab. pmid:25605290
Jeon ES et al. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. 2006 J. Cell. Sci. pmid:17105765
Busch T et al. Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. 2012 J. Cell. Sci. pmid:22344252
Hyder CL et al. Sphingolipids inhibit vimentin-dependent cell migration. 2015 J. Cell. Sci. pmid:25908861
Ge D et al. Regulation of apoptosis and autophagy by sphingosylphosphorylcholine in vascular endothelial cells. 2011 J. Cell. Physiol. pmid:21302284
Xu Y et al. Effect of lysophospholipids on signaling in the human Jurkat T cell line. 1995 J. Cell. Physiol. pmid:7775587
Kostenis E Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. 2004 J. Cell. Biochem. pmid:15258916
Jeon ES et al. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK. 2007 J. Cell. Biochem. pmid:17131361
Kanazawa T et al. Inhibition of cytokinesis by a lipid metabolite, psychosine. 2000 J. Cell Biol. pmid:10811833
Desai NN et al. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. 1993 J. Cell Biol. pmid:8389770
Lyons JM and Karin NJ A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. 2001 J. Bone Miner. Res. pmid:11697799
Jeong HS et al. Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects. 2011 J. Biomed. Sci. pmid:21838918
Okajima F and Kondo Y Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. 1995 J. Biol. Chem. pmid:7592844
Nofer JR et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. 2001 J. Biol. Chem. pmid:11432865
Sakagami H et al. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. 2005 J. Biol. Chem. pmid:15788404